{"transactions":[{"id":699860,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":27470,"kind":"person","name":"Nighan Warren JR","position":1,"cik":"0001507345","reported_name":"Nighan Warren JR","relationship":{"officer":true,"officer_title":"SVP Quality and Regulatory"}}],"security":"Common Stock","published_at":"2026-07-31T20:45:07.000Z","date":"2026-07-30","kind":"sale","planned":false,"acquired":false,"shares":23370,"price":14.72,"value":344006.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.65 to $14.80, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1."}],"balance_after":64745,"source":{"system":"sec-edgar","filing":"0001140361-26-030514","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126030514/form4.xml","form_type":"4"}},{"id":703553,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28803,"kind":"person","name":"Piccinini Laura","position":1,"cik":"0001875140","reported_name":"Piccinini Laura","relationship":{"officer":true,"officer_title":"SVP International"}}],"security":"Performance Right","published_at":"2026-07-24T22:10:55.000Z","date":"2026-07-22","kind":"exercise","planned":false,"acquired":false,"shares":28336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 28,336 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 8,047 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 28,336 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 8,047 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 28,336 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 8,047 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":28336},"source":{"system":"sec-edgar","filing":"0001140361-26-029636","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875140/000114036126029636/form4.xml","form_type":"4"}},{"id":703552,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28803,"kind":"person","name":"Piccinini Laura","position":1,"cik":"0001875140","reported_name":"Piccinini Laura","relationship":{"officer":true,"officer_title":"SVP International"}}],"security":"Common Stock","published_at":"2026-07-24T22:10:55.000Z","date":"2026-07-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":4506,"price":13.82,"value":62272.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 4,506 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023."}],"balance_after":81929,"source":{"system":"sec-edgar","filing":"0001140361-26-029636","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875140/000114036126029636/form4.xml","form_type":"4"}},{"id":703551,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28803,"kind":"person","name":"Piccinini Laura","position":1,"cik":"0001875140","reported_name":"Piccinini Laura","relationship":{"officer":true,"officer_title":"SVP International"}}],"security":"Common Stock","published_at":"2026-07-24T22:10:55.000Z","date":"2026-07-22","kind":"exercise","planned":false,"acquired":true,"shares":8047,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 8,047 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. (\"AngioDynamics\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023."}],"balance_after":86435,"source":{"system":"sec-edgar","filing":"0001140361-26-029636","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875140/000114036126029636/form4.xml","form_type":"4"}},{"id":703432,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":27470,"kind":"person","name":"Nighan Warren JR","position":1,"cik":"0001507345","reported_name":"Nighan Warren JR","relationship":{"officer":true,"officer_title":"SVP Quality and Regulatory"}}],"security":"Performance Right","published_at":"2026-07-24T22:10:54.000Z","date":"2026-07-22","kind":"exercise","planned":false,"acquired":false,"shares":20052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 20,052 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 5,694 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 20,052 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 5,694 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 20,052 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 5,694 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20052},"source":{"system":"sec-edgar","filing":"0001140361-26-029635","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029635/form4.xml","form_type":"4"}},{"id":703431,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":27470,"kind":"person","name":"Nighan Warren JR","position":1,"cik":"0001507345","reported_name":"Nighan Warren JR","relationship":{"officer":true,"officer_title":"SVP Quality and Regulatory"}}],"security":"Common Stock","published_at":"2026-07-24T22:10:54.000Z","date":"2026-07-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":1671,"price":13.82,"value":23093.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 1,671 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023."}],"balance_after":88115,"source":{"system":"sec-edgar","filing":"0001140361-26-029635","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029635/form4.xml","form_type":"4"}},{"id":703430,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":27470,"kind":"person","name":"Nighan Warren JR","position":1,"cik":"0001507345","reported_name":"Nighan Warren JR","relationship":{"officer":true,"officer_title":"SVP Quality and Regulatory"}}],"security":"Common Stock","published_at":"2026-07-24T22:10:54.000Z","date":"2026-07-22","kind":"exercise","planned":false,"acquired":true,"shares":5694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 5,694 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. (\"AngioDynamics\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023."}],"balance_after":89786,"source":{"system":"sec-edgar","filing":"0001140361-26-029635","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029635/form4.xml","form_type":"4"}},{"id":703428,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2026-07-24T22:10:53.000Z","date":"2026-07-22","kind":"exercise","planned":false,"acquired":false,"shares":57381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 57,381 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 16,296 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 57,381 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 16,296 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 57,381 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 16,296 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":57381},"source":{"system":"sec-edgar","filing":"0001140361-26-029634","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029634/form4.xml","form_type":"4"}},{"id":703427,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-07-24T22:10:53.000Z","date":"2026-07-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":8319,"price":13.82,"value":114968.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 8,319 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023."}],"balance_after":305796,"source":{"system":"sec-edgar","filing":"0001140361-26-029634","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029634/form4.xml","form_type":"4"}},{"id":703426,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-07-24T22:10:53.000Z","date":"2026-07-22","kind":"exercise","planned":false,"acquired":true,"shares":16296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 16,296 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. (\"AngioDynamics\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023."}],"balance_after":314115,"source":{"system":"sec-edgar","filing":"0001140361-26-029634","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029634/form4.xml","form_type":"4"}},{"id":703491,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2026-07-24T22:10:51.000Z","date":"2026-07-22","kind":"exercise","planned":false,"acquired":false,"shares":184361,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 184,361 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 52,358 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 184,361 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 52,358 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 184,361 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 52,358 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":184361},"source":{"system":"sec-edgar","filing":"0001140361-26-029633","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036126029633/form4.xml","form_type":"4"}},{"id":703490,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-24T22:10:51.000Z","date":"2026-07-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":26728,"price":13.82,"value":369380.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 26,728 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023."}],"balance_after":862448,"source":{"system":"sec-edgar","filing":"0001140361-26-029633","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036126029633/form4.xml","form_type":"4"}},{"id":703489,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-24T22:10:51.000Z","date":"2026-07-22","kind":"exercise","planned":false,"acquired":true,"shares":52358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 52,358 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. (\"AngioDynamics\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023."}],"balance_after":889176,"source":{"system":"sec-edgar","filing":"0001140361-26-029633","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036126029633/form4.xml","form_type":"4"}},{"id":703425,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance Right","published_at":"2026-07-24T22:10:50.000Z","date":"2026-07-22","kind":"exercise","planned":false,"acquired":false,"shares":22768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 22,768 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 6,466 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 22,768 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 6,466 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 22,768 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 6,466 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":22768},"source":{"system":"sec-edgar","filing":"0001140361-26-029632","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029632/form4.xml","form_type":"4"}},{"id":703424,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2026-07-24T22:10:50.000Z","date":"2026-07-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":2330,"price":13.82,"value":32200.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 2,330 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023."}],"balance_after":108676,"source":{"system":"sec-edgar","filing":"0001140361-26-029632","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029632/form4.xml","form_type":"4"}},{"id":703423,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2026-07-24T22:10:50.000Z","date":"2026-07-22","kind":"exercise","planned":false,"acquired":true,"shares":6466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 6,466 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. (\"AngioDynamics\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023."}],"balance_after":111006,"source":{"system":"sec-edgar","filing":"0001140361-26-029632","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029632/form4.xml","form_type":"4"}},{"id":704858,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":18820,"kind":"person","name":"REED JAN STERN","position":1,"cik":"0001124181","reported_name":"REED JAN STERN","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-23T00:06:15.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":11887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant."}],"balance_after":116921,"source":{"system":"sec-edgar","filing":"0001140361-26-029341","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124181/000114036126029341/form4.xml","form_type":"4"}},{"id":704639,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29136,"kind":"person","name":"Licitra Karen A","position":1,"cik":"0001754757","reported_name":"Licitra Karen A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-23T00:06:14.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":11887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant."}],"balance_after":102322,"source":{"system":"sec-edgar","filing":"0001140361-26-029340","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029340/form4.xml","form_type":"4"}},{"id":704655,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29141,"kind":"person","name":"JOHNSON WESLEY","position":1,"cik":"0001258791","reported_name":"JOHNSON WESLEY","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-23T00:06:13.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":11887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant."}],"balance_after":155425,"source":{"system":"sec-edgar","filing":"0001140361-26-029339","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258791/000114036126029339/form4.xml","form_type":"4"}},{"id":704643,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29138,"kind":"person","name":"DONNELLY HOWARD W","position":1,"cik":"0001212978","reported_name":"DONNELLY HOWARD W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-23T00:06:12.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":11887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant."}],"balance_after":178938,"source":{"system":"sec-edgar","filing":"0001140361-26-029338","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212978/000114036126029338/form4.xml","form_type":"4"}},{"id":704638,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29135,"kind":"person","name":"Burgess Lorinda","position":1,"cik":"0001843912","reported_name":"Burgess Lorinda","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-23T00:06:11.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":11887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant."}],"balance_after":67144,"source":{"system":"sec-edgar","filing":"0001140361-26-029337","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029337/form4.xml","form_type":"4"}},{"id":704674,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29149,"kind":"person","name":"Auen Eileen O'Shea","position":1,"cik":"0001428073","reported_name":"Auen Eileen O'Shea","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-23T00:06:09.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":11887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant."}],"balance_after":116605,"source":{"system":"sec-edgar","filing":"0001140361-26-029336","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428073/000114036126029336/form4.xml","form_type":"4"}},{"id":704637,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29134,"kind":"person","name":"Tarnoff Michael E","position":1,"cik":"0001603289","reported_name":"Tarnoff Michael E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-23T00:06:08.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":11887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant."}],"balance_after":95265,"source":{"system":"sec-edgar","filing":"0001140361-26-029335","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029335/form4.xml","form_type":"4"}},{"id":704636,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2026-07-23T00:06:07.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":53257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":53257,"derivative":{"underlying":"Common Stock","underlying_shares":53257},"source":{"system":"sec-edgar","filing":"0001140361-26-029334","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029334/form4.xml","form_type":"4"}},{"id":704635,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-07-23T00:06:07.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":53257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 53,257 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 53,257 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 15, 2027, such that 25% of the restricted stock units will vest on each of July 15, 2027, 2028, 2029 and 2030."}],"balance_after":297819,"source":{"system":"sec-edgar","filing":"0001140361-26-029334","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029334/form4.xml","form_type":"4"}},{"id":704789,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28803,"kind":"person","name":"Piccinini Laura","position":1,"cik":"0001875140","reported_name":"Piccinini Laura","relationship":{"officer":true,"officer_title":"SVP International"}}],"security":"Performance Right","published_at":"2026-07-23T00:06:06.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":19860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":19860,"derivative":{"underlying":"Common Stock","underlying_shares":19860},"source":{"system":"sec-edgar","filing":"0001140361-26-029333","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875140/000114036126029333/form4.xml","form_type":"4"}},{"id":704788,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28803,"kind":"person","name":"Piccinini Laura","position":1,"cik":"0001875140","reported_name":"Piccinini Laura","relationship":{"officer":true,"officer_title":"SVP International"}}],"security":"Common Stock","published_at":"2026-07-23T00:06:06.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":19860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 19,860 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 19,860 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 15, 2027, such that 25% of the restricted stock units will vest on each of July 15, 2027, 2028, 2029 and 2030."}],"balance_after":78388,"source":{"system":"sec-edgar","filing":"0001140361-26-029333","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875140/000114036126029333/form4.xml","form_type":"4"}},{"id":704634,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":27470,"kind":"person","name":"Nighan Warren JR","position":1,"cik":"0001507345","reported_name":"Nighan Warren JR","relationship":{"officer":true,"officer_title":"SVP Quality and Regulatory"}}],"security":"Performance Right","published_at":"2026-07-23T00:06:04.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":17966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":17966,"derivative":{"underlying":"Common Stock","underlying_shares":17966},"source":{"system":"sec-edgar","filing":"0001140361-26-029332","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029332/form4.xml","form_type":"4"}},{"id":704633,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":27470,"kind":"person","name":"Nighan Warren JR","position":1,"cik":"0001507345","reported_name":"Nighan Warren JR","relationship":{"officer":true,"officer_title":"SVP Quality and Regulatory"}}],"security":"Common Stock","published_at":"2026-07-23T00:06:04.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":17966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 17,966 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 17,966 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 15, 2027, such that 25% of the restricted stock units will vest on each of July 15, 2027, 2028, 2029 and 2030."}],"balance_after":84092,"source":{"system":"sec-edgar","filing":"0001140361-26-029332","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029332/form4.xml","form_type":"4"}},{"id":704632,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance Right","published_at":"2026-07-23T00:06:03.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":16081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":16081,"derivative":{"underlying":"Common Stock","underlying_shares":16081},"source":{"system":"sec-edgar","filing":"0001140361-26-029331","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029331/form4.xml","form_type":"4"}},{"id":704631,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2026-07-23T00:06:03.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":16081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 16,081 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 16,081 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 15, 2027, such that 25% of the restricted stock units will vest on each of July 15, 2027, 2028, 2029 and 2030."}],"balance_after":104540,"source":{"system":"sec-edgar","filing":"0001140361-26-029331","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029331/form4.xml","form_type":"4"}},{"id":704630,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"officer":true,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Performance Right","published_at":"2026-07-23T00:06:02.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":21288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":21288,"derivative":{"underlying":"Common Stock","underlying_shares":21288},"source":{"system":"sec-edgar","filing":"0001140361-26-029330","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029330/form4.xml","form_type":"4"}},{"id":704629,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"officer":true,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-07-23T00:06:02.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":21288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 21,288 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 21,288 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 15, 2027, such that 25% of the restricted stock units will vest on each of July 15, 2027, 2028, 2029 and 2030."}],"balance_after":112618,"source":{"system":"sec-edgar","filing":"0001140361-26-029330","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029330/form4.xml","form_type":"4"}},{"id":705131,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"officer":true,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-07-22T00:36:47.000Z","date":"2026-07-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":2267,"price":14.14,"value":32055.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 2,267 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025."}],"balance_after":91330,"source":{"system":"sec-edgar","filing":"0001140361-26-029190","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029190/form4.xml","form_type":"4"}},{"id":705130,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-07-22T00:32:05.000Z","date":"2026-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":717,"price":13.71,"value":9830.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 717 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":244562,"source":{"system":"sec-edgar","filing":"0001140361-26-029188","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029188/form4.xml","form_type":"4"}},{"id":705129,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-07-22T00:32:05.000Z","date":"2026-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":3510,"price":13.51,"value":47420.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 3,510 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024."}],"balance_after":245279,"source":{"system":"sec-edgar","filing":"0001140361-26-029188","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029188/form4.xml","form_type":"4"}},{"id":705128,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-07-22T00:32:05.000Z","date":"2026-07-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":7840,"price":14.14,"value":110857.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 7,840 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025."}],"balance_after":248789,"source":{"system":"sec-edgar","filing":"0001140361-26-029188","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029188/form4.xml","form_type":"4"}},{"id":705232,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28803,"kind":"person","name":"Piccinini Laura","position":1,"cik":"0001875140","reported_name":"Piccinini Laura","relationship":{"officer":true,"officer_title":"SVP International"}}],"security":"Common Stock","published_at":"2026-07-22T00:28:28.000Z","date":"2026-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":616,"price":13.71,"value":8445.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 616 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":58528,"source":{"system":"sec-edgar","filing":"0001140361-26-029185","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875140/000114036126029185/form4.xml","form_type":"4"}},{"id":705231,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28803,"kind":"person","name":"Piccinini Laura","position":1,"cik":"0001875140","reported_name":"Piccinini Laura","relationship":{"officer":true,"officer_title":"SVP International"}}],"security":"Common Stock","published_at":"2026-07-22T00:28:28.000Z","date":"2026-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":3074,"price":13.51,"value":41529.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 3,074 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024."}],"balance_after":59144,"source":{"system":"sec-edgar","filing":"0001140361-26-029185","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875140/000114036126029185/form4.xml","form_type":"4"}},{"id":705230,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28803,"kind":"person","name":"Piccinini Laura","position":1,"cik":"0001875140","reported_name":"Piccinini Laura","relationship":{"officer":true,"officer_title":"SVP International"}}],"security":"Common Stock","published_at":"2026-07-22T00:28:28.000Z","date":"2026-07-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":4538,"price":14.14,"value":64167.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 4,538 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025."}],"balance_after":62218,"source":{"system":"sec-edgar","filing":"0001140361-26-029185","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875140/000114036126029185/form4.xml","form_type":"4"}},{"id":705127,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":27470,"kind":"person","name":"Nighan Warren JR","position":1,"cik":"0001507345","reported_name":"Nighan Warren JR","relationship":{"officer":true,"officer_title":"SVP Quality and Regulatory"}}],"security":"Common Stock","published_at":"2026-07-22T00:21:29.000Z","date":"2026-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":251,"price":13.71,"value":3441.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 251 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":66126,"source":{"system":"sec-edgar","filing":"0001140361-26-029181","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029181/form4.xml","form_type":"4"}},{"id":705126,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":27470,"kind":"person","name":"Nighan Warren JR","position":1,"cik":"0001507345","reported_name":"Nighan Warren JR","relationship":{"officer":true,"officer_title":"SVP Quality and Regulatory"}}],"security":"Common Stock","published_at":"2026-07-22T00:21:29.000Z","date":"2026-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":1373,"price":13.51,"value":18549.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 1,373 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024."}],"balance_after":66377,"source":{"system":"sec-edgar","filing":"0001140361-26-029181","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029181/form4.xml","form_type":"4"}},{"id":705125,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":27470,"kind":"person","name":"Nighan Warren JR","position":1,"cik":"0001507345","reported_name":"Nighan Warren JR","relationship":{"officer":true,"officer_title":"SVP Quality and Regulatory"}}],"security":"Common Stock","published_at":"2026-07-22T00:21:29.000Z","date":"2026-07-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":2153,"price":14.14,"value":30443.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 2,153 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025."}],"balance_after":67750,"source":{"system":"sec-edgar","filing":"0001140361-26-029181","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029181/form4.xml","form_type":"4"}},{"id":705174,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-22T00:17:04.000Z","date":"2026-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":4223,"price":13.71,"value":57897.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The exempt disposition of 4,223 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":836818,"source":{"system":"sec-edgar","filing":"0001140361-26-029178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036126029178/form4.xml","form_type":"4"}},{"id":705173,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-22T00:17:04.000Z","date":"2026-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":487,"price":13.51,"value":6579.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The exempt disposition of 487 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2024."}],"balance_after":841041,"source":{"system":"sec-edgar","filing":"0001140361-26-029178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036126029178/form4.xml","form_type":"4"}},{"id":705172,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-22T00:17:04.000Z","date":"2026-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":11764,"price":13.51,"value":158931.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 11,764 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2023."}],"balance_after":841528,"source":{"system":"sec-edgar","filing":"0001140361-26-029178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036126029178/form4.xml","form_type":"4"}},{"id":705171,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-22T00:17:04.000Z","date":"2026-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":10649,"price":13.51,"value":143867.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 10,649 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024."}],"balance_after":853292,"source":{"system":"sec-edgar","filing":"0001140361-26-029178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036126029178/form4.xml","form_type":"4"}},{"id":705170,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-22T00:17:04.000Z","date":"2026-07-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":18588,"price":14.14,"value":262834.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 18,588 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025."}],"balance_after":863941,"source":{"system":"sec-edgar","filing":"0001140361-26-029178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036126029178/form4.xml","form_type":"4"}},{"id":705124,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2026-07-22T00:10:40.000Z","date":"2026-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":359,"price":13.71,"value":4921.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 359 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":88459,"source":{"system":"sec-edgar","filing":"0001140361-26-029176","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029176/form4.xml","form_type":"4"}},{"id":705123,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2026-07-22T00:10:40.000Z","date":"2026-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":1112,"price":13.51,"value":15023.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 1,112 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024."}],"balance_after":88818,"source":{"system":"sec-edgar","filing":"0001140361-26-029176","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029176/form4.xml","form_type":"4"}},{"id":705122,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2026-07-22T00:10:40.000Z","date":"2026-07-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":2367,"price":14.14,"value":33469.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 2,367 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025."}],"balance_after":89930,"source":{"system":"sec-edgar","filing":"0001140361-26-029176","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029176/form4.xml","form_type":"4"}},{"id":1014572,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"officer":true,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-10-22T11:00:16.000Z","date":"2025-10-21","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":11.81,"value":118100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.71 to $11.90, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1."}],"balance_after":93597,"source":{"system":"sec-edgar","filing":"0001140361-25-038873","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125038873/form4.xml","form_type":"4"}},{"id":1019081,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-10-14T10:11:34.000Z","date":"2025-10-13","kind":"purchase","planned":false,"acquired":true,"shares":890,"price":11.16,"value":9932.4,"ownership":{"direct":true},"balance_after":256629,"source":{"system":"sec-edgar","filing":"0001140361-25-038018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125038018/form4.xml","form_type":"4"}},{"id":1020802,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-10-10T01:09:24.000Z","date":"2025-10-09","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":11.15,"value":111500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $11.10 to $11.17 inclusive.  The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1."}],"balance_after":882529,"source":{"system":"sec-edgar","filing":"0001140361-25-037836","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036125037836/form4.xml","form_type":"4"}},{"id":1083290,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:23.000Z","date":"2025-07-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":667,"price":8.99,"value":5996.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 667 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 21, 2021."}],"balance_after":255739,"source":{"system":"sec-edgar","filing":"0001140361-25-026800","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026800/form4.xml","form_type":"4"}},{"id":1083289,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:23.000Z","date":"2025-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":717,"price":8.69,"value":6230.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 717 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":256406,"source":{"system":"sec-edgar","filing":"0001140361-25-026800","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026800/form4.xml","form_type":"4"}},{"id":1083288,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:23.000Z","date":"2025-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":2585,"price":8.69,"value":22463.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 2,585 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2023."}],"balance_after":257123,"source":{"system":"sec-edgar","filing":"0001140361-25-026800","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026800/form4.xml","form_type":"4"}},{"id":1083486,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28803,"kind":"person","name":"Piccinini Laura","position":1,"cik":"0001875140","reported_name":"Piccinini Laura","relationship":{"officer":true,"officer_title":"SVP International"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:21.000Z","date":"2025-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":616,"price":8.69,"value":5353.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 616 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":66756,"source":{"system":"sec-edgar","filing":"0001140361-25-026799","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875140/000114036125026799/form4.xml","form_type":"4"}},{"id":1083485,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28803,"kind":"person","name":"Piccinini Laura","position":1,"cik":"0001875140","reported_name":"Piccinini Laura","relationship":{"officer":true,"officer_title":"SVP International"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:21.000Z","date":"2025-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1983,"price":8.69,"value":17232.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 1,983 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2023."}],"balance_after":67372,"source":{"system":"sec-edgar","filing":"0001140361-25-026799","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875140/000114036125026799/form4.xml","form_type":"4"}},{"id":1083293,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":27470,"kind":"person","name":"Nighan Warren JR","position":1,"cik":"0001507345","reported_name":"Nighan Warren JR","relationship":{"officer":true,"officer_title":"SVP Quality and Regulatory"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:20.000Z","date":"2025-07-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":277,"price":8.99,"value":2490.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 277 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 21, 2021."}],"balance_after":69903,"source":{"system":"sec-edgar","filing":"0001140361-25-026798","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026798/form4.xml","form_type":"4"}},{"id":1083292,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":27470,"kind":"person","name":"Nighan Warren JR","position":1,"cik":"0001507345","reported_name":"Nighan Warren JR","relationship":{"officer":true,"officer_title":"SVP Quality and Regulatory"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:20.000Z","date":"2025-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":251,"price":8.69,"value":2181.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 251 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":70180,"source":{"system":"sec-edgar","filing":"0001140361-25-026798","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026798/form4.xml","form_type":"4"}},{"id":1083291,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":27470,"kind":"person","name":"Nighan Warren JR","position":1,"cik":"0001507345","reported_name":"Nighan Warren JR","relationship":{"officer":true,"officer_title":"SVP Quality and Regulatory"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:20.000Z","date":"2025-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":735,"price":8.69,"value":6387.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 735 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2023."}],"balance_after":70431,"source":{"system":"sec-edgar","filing":"0001140361-25-026798","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026798/form4.xml","form_type":"4"}},{"id":1083333,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:18.000Z","date":"2025-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":3673,"price":8.99,"value":33020.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The exempt disposition of 3,673 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 21, 2021."}],"balance_after":872529,"source":{"system":"sec-edgar","filing":"0001140361-25-026797","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036125026797/form4.xml","form_type":"4"}},{"id":1083332,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:18.000Z","date":"2025-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":2982,"price":8.69,"value":25913.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 2,982 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":876202,"source":{"system":"sec-edgar","filing":"0001140361-25-026797","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036125026797/form4.xml","form_type":"4"}},{"id":1083331,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:18.000Z","date":"2025-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":8307,"price":8.69,"value":72187.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 8,307 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2023."}],"balance_after":879184,"source":{"system":"sec-edgar","filing":"0001140361-25-026797","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036125026797/form4.xml","form_type":"4"}},{"id":1083330,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:18.000Z","date":"2025-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":344,"price":8.69,"value":2989.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 344 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2024."}],"balance_after":887491,"source":{"system":"sec-edgar","filing":"0001140361-25-026797","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036125026797/form4.xml","form_type":"4"}},{"id":1083287,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:16.000Z","date":"2025-07-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":395,"price":8.99,"value":3551.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 395 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 21, 2021."}],"balance_after":92297,"source":{"system":"sec-edgar","filing":"0001140361-25-026796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026796/form4.xml","form_type":"4"}},{"id":1083286,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:16.000Z","date":"2025-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":359,"price":8.69,"value":3119.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 359 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":92692,"source":{"system":"sec-edgar","filing":"0001140361-25-026796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026796/form4.xml","form_type":"4"}},{"id":1083285,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:16.000Z","date":"2025-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1025,"price":8.69,"value":8907.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 1,025 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2023."}],"balance_after":93051,"source":{"system":"sec-edgar","filing":"0001140361-25-026796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026796/form4.xml","form_type":"4"}},{"id":1084120,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28803,"kind":"person","name":"Piccinini Laura","position":1,"cik":"0001875140","reported_name":"Piccinini Laura","relationship":{"officer":true,"officer_title":"SVP International"}}],"security":"Common Stock","published_at":"2025-07-21T21:55:52.000Z","date":"2025-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":3074,"price":8.74,"value":26866.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 3,074 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024"}],"balance_after":69355,"source":{"system":"sec-edgar","filing":"0001140361-25-026633","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875140/000114036125026633/form4.xml","form_type":"4"}},{"id":1084585,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":27470,"kind":"person","name":"Nighan Warren JR","position":1,"cik":"0001507345","reported_name":"Nighan Warren JR","relationship":{"officer":true,"officer_title":"SVP Quality and Regulatory"}}],"security":"Performance Right","published_at":"2025-07-18T22:06:29.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":29349,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":29349,"derivative":{"underlying":"Common Stock","underlying_shares":29349},"source":{"system":"sec-edgar","filing":"0001140361-25-026465","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026465/form4.xml","form_type":"4"}},{"id":1084584,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":27470,"kind":"person","name":"Nighan Warren JR","position":1,"cik":"0001507345","reported_name":"Nighan Warren JR","relationship":{"officer":true,"officer_title":"SVP Quality and Regulatory"}}],"security":"Common Stock","published_at":"2025-07-18T22:06:29.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":29349,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 29,349 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 29,349 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 16, 2026, such that 25% of the restricted stock units will vest on each of July 16, 2026, 2027, 2028 and 2029."}],"balance_after":71166,"source":{"system":"sec-edgar","filing":"0001140361-25-026465","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026465/form4.xml","form_type":"4"}},{"id":1084661,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2025-07-18T22:06:27.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":206253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":206253,"derivative":{"underlying":"Common Stock","underlying_shares":206253},"source":{"system":"sec-edgar","filing":"0001140361-25-026464","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036125026464/form4.xml","form_type":"4"}},{"id":1084660,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-18T22:06:27.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":206253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 206,253 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 206,253 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 16, 2026, such that 25% of the restricted stock units will vest on each of July 16, 2026, 2027, 2028 and 2029."}],"balance_after":887835,"source":{"system":"sec-edgar","filing":"0001140361-25-026464","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036125026464/form4.xml","form_type":"4"}},{"id":1084583,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"officer":true,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Performance Right","published_at":"2025-07-18T22:06:25.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":30900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":30900,"derivative":{"underlying":"Common Stock","underlying_shares":30900},"source":{"system":"sec-edgar","filing":"0001140361-25-026463","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026463/form4.xml","form_type":"4"}},{"id":1084582,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"officer":true,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-07-18T22:06:25.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":30900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 30,900 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 30,900 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 16, 2026, such that 25% of the restricted stock units will vest on each of July 16, 2026, 2027, 2028 and 2029."}],"balance_after":83597,"source":{"system":"sec-edgar","filing":"0001140361-25-026463","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026463/form4.xml","form_type":"4"}},{"id":1084581,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Performance Right","published_at":"2025-07-18T22:06:23.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":86997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":86997,"derivative":{"underlying":"Common Stock","underlying_shares":86997},"source":{"system":"sec-edgar","filing":"0001140361-25-026462","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026462/form4.xml","form_type":"4"}},{"id":1084580,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-07-18T22:06:23.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":86997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 86,997 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 86,997 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 16, 2026, such that 25% of the restricted stock units will vest on each of July 16, 2026, 2027, 2028 and 2029."}],"balance_after":259708,"source":{"system":"sec-edgar","filing":"0001140361-25-026462","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026462/form4.xml","form_type":"4"}},{"id":1084579,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance Right","published_at":"2025-07-18T22:06:21.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":26268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":26268,"derivative":{"underlying":"Common Stock","underlying_shares":26268},"source":{"system":"sec-edgar","filing":"0001140361-25-026461","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026461/form4.xml","form_type":"4"}},{"id":1084578,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2025-07-18T22:06:21.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":26268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 26,268 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 26,268 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 16, 2026, such that 25% of the restricted stock units will vest on each of July 16, 2026, 2027, 2028 and 2029."}],"balance_after":94076,"source":{"system":"sec-edgar","filing":"0001140361-25-026461","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026461/form4.xml","form_type":"4"}},{"id":1084587,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29138,"kind":"person","name":"DONNELLY HOWARD W","position":1,"cik":"0001212978","reported_name":"DONNELLY HOWARD W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-18T22:06:20.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":17675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 17,675 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") represents 17,675 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant."}],"balance_after":167051,"source":{"system":"sec-edgar","filing":"0001140361-25-026460","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212978/000114036125026460/form4.xml","form_type":"4"}},{"id":1084776,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28803,"kind":"person","name":"Piccinini Laura","position":1,"cik":"0001875140","reported_name":"Piccinini Laura","relationship":{"officer":true,"officer_title":"SVP International"}}],"security":"Performance Right","published_at":"2025-07-18T22:06:18.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":32423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":32423,"derivative":{"underlying":"Common Stock","underlying_shares":32423},"source":{"system":"sec-edgar","filing":"0001140361-25-026466","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875140/000114036125026466/form4.xml","form_type":"4"}},{"id":1084775,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28803,"kind":"person","name":"Piccinini Laura","position":1,"cik":"0001875140","reported_name":"Piccinini Laura","relationship":{"officer":true,"officer_title":"SVP International"}}],"security":"Common Stock","published_at":"2025-07-18T22:06:18.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":32423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 32,423 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 32,423 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 16, 2026, such that 25% of the restricted stock units will vest on each of July 16, 2026, 2027, 2028 and 2029."}],"balance_after":72429,"source":{"system":"sec-edgar","filing":"0001140361-25-026466","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875140/000114036125026466/form4.xml","form_type":"4"}},{"id":1084577,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29135,"kind":"person","name":"Burgess Lorinda","position":1,"cik":"0001843912","reported_name":"Burgess Lorinda","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-18T22:06:18.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":17675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 17,675 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") represents 17,675 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant."}],"balance_after":55257,"source":{"system":"sec-edgar","filing":"0001140361-25-026459","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026459/form4.xml","form_type":"4"}},{"id":1084648,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29149,"kind":"person","name":"Auen Eileen O'Shea","position":1,"cik":"0001428073","reported_name":"Auen Eileen O'Shea","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-18T22:06:16.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":17675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 17,675 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") represents 17,675 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant."}],"balance_after":104718,"source":{"system":"sec-edgar","filing":"0001140361-25-026458","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428073/000114036125026458/form4.xml","form_type":"4"}},{"id":1084576,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29134,"kind":"person","name":"Tarnoff Michael E","position":1,"cik":"0001603289","reported_name":"Tarnoff Michael E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-18T22:06:14.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":17675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 17,675 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") represents 17,675 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant."}],"balance_after":83378,"source":{"system":"sec-edgar","filing":"0001140361-25-026457","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026457/form4.xml","form_type":"4"}},{"id":1084862,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":18820,"kind":"person","name":"REED JAN STERN","position":1,"cik":"0001124181","reported_name":"REED JAN STERN","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-18T22:06:13.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":17675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 17,675 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") represents 17,675 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant."}],"balance_after":105034,"source":{"system":"sec-edgar","filing":"0001140361-25-026456","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124181/000114036125026456/form4.xml","form_type":"4"}},{"id":1084575,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29136,"kind":"person","name":"Licitra Karen A","position":1,"cik":"0001754757","reported_name":"Licitra Karen A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-18T22:06:11.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":17675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 17,675 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") represents 17,675 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant."}],"balance_after":90435,"source":{"system":"sec-edgar","filing":"0001140361-25-026455","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026455/form4.xml","form_type":"4"}},{"id":1084595,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29141,"kind":"person","name":"JOHNSON WESLEY","position":1,"cik":"0001258791","reported_name":"JOHNSON WESLEY","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-18T22:06:09.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":17675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 17,675 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") represents 17,675 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant."}],"balance_after":143538,"source":{"system":"sec-edgar","filing":"0001140361-25-026454","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258791/000114036125026454/form4.xml","form_type":"4"}},{"id":1299831,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":27470,"kind":"person","name":"Nighan Warren JR","position":1,"cik":"0001507345","reported_name":"Nighan Warren JR","relationship":{"officer":true,"officer_title":"SVP Quality and Regulatory"}}],"security":"Common Stock","published_at":"2025-01-17T21:05:54.000Z","date":"2025-01-16","kind":"sale","planned":false,"acquired":false,"shares":4060,"price":12.31,"value":49978.6,"ownership":{"direct":true},"balance_after":41817,"source":{"system":"sec-edgar","filing":"0001140361-25-001388","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125001388/form4.xml","form_type":"4"}},{"id":1342692,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"officer":true,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-12-05T02:33:45.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":103650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These stock options vest in four equal annual installments beginning on December 2, 2025, such that 25% of the options will vest on each of December 2, 2025, 2026, 2027 and 2028."}],"balance_after":103650,"derivative":{"exercise_price":7.14,"exercise_date":"2025-12-02","expiration_date":"2034-12-02","underlying":"Common Stock","underlying_shares":103650},"source":{"system":"sec-edgar","filing":"0001140361-24-048416","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124048416/form4.xml","form_type":"4"}},{"id":1342691,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"officer":true,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-12-05T02:33:45.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":52697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 52,697 shares of common stock (\"Common Stock\") of AngioDynamics, Inc.(\"AngioDynamics\") represents 52,697 restricted stock units, each of which represents a contingent right to receive one share of Common Stock.  These restricted stock units vest in four equal annual installments beginning on December 2, 2025, such that 25% of the restricted stock units will vest on each of December 2, 2025, 2026, 2027 and 2028."}],"balance_after":52697,"source":{"system":"sec-edgar","filing":"0001140361-24-048416","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124048416/form4.xml","form_type":"4"}},{"id":1388041,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":27470,"kind":"person","name":"Nighan Warren JR","position":1,"cik":"0001507345","reported_name":"Nighan Warren JR","relationship":{"officer":true,"officer_title":"SVP Quality and Regulatory"}}],"security":"Common Stock","published_at":"2024-10-10T19:22:57.000Z","date":"2024-10-10","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":6.08,"value":608.0,"ownership":{"direct":true},"balance_after":45877,"source":{"system":"sec-edgar","filing":"0001140361-24-043263","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124043263/form4.xml","form_type":"4"}},{"id":1388040,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":27470,"kind":"person","name":"Nighan Warren JR","position":1,"cik":"0001507345","reported_name":"Nighan Warren JR","relationship":{"officer":true,"officer_title":"SVP Quality and Regulatory"}}],"security":"Common Stock","published_at":"2024-10-10T19:22:57.000Z","date":"2024-10-07","kind":"purchase","planned":false,"acquired":true,"shares":768,"price":6.09,"value":4677.12,"ownership":{"direct":true},"balance_after":45777,"source":{"system":"sec-edgar","filing":"0001140361-24-043263","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124043263/form4.xml","form_type":"4"}},{"id":1389183,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28738,"kind":"person","name":"Trowbridge Stephen A","position":1,"cik":"0001624250","reported_name":"Trowbridge Stephen A","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2024-10-08T22:27:36.000Z","date":"2024-10-08","kind":"purchase","planned":false,"acquired":true,"shares":1700,"price":5.86,"value":9962.0,"ownership":{"direct":true},"balance_after":172711,"source":{"system":"sec-edgar","filing":"0001140361-24-043173","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124043173/form4.xml","form_type":"4"}},{"id":1389266,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-08T20:32:02.000Z","date":"2024-10-07","kind":"purchase","planned":true,"acquired":true,"shares":20000,"price":6.03,"value":120600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $5.95 to $6.08 inclusive.  The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1."}],"balance_after":681582,"source":{"system":"sec-edgar","filing":"0001140361-24-043157","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036124043157/form4.xml","form_type":"4"}},{"id":1443105,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28803,"kind":"person","name":"Piccinini Laura","position":1,"cik":"0001875140","reported_name":"Piccinini Laura","relationship":{"officer":true,"officer_title":"SVP International"}}],"security":"Performance Right","published_at":"2024-08-03T01:55:48.000Z","date":"2024-07-17","kind":"exercise","planned":false,"acquired":true,"shares":5903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 21, 2021, the reporting person received a target grant of 5,903 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2022, 2023 and 2024 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 4,439 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 21, 2021, the reporting person received a target grant of 5,903 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2022, 2023 and 2024 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 4,439 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 21, 2021, the reporting person received a target grant of 5,903 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2022, 2023 and 2024 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 4,439 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5903},"source":{"system":"sec-edgar","filing":"0001140361-24-035601","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875140/000114036124035601/form4.xml","form_type":"4"}},{"id":1443104,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28803,"kind":"person","name":"Piccinini Laura","position":1,"cik":"0001875140","reported_name":"Piccinini Laura","relationship":{"officer":true,"officer_title":"SVP International"}}],"security":"Common Stock","published_at":"2024-08-03T01:55:48.000Z","date":"2024-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":2485,"price":7.4,"value":18389.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 2,485 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 21, 2021."}],"balance_after":40006,"source":{"system":"sec-edgar","filing":"0001140361-24-035601","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875140/000114036124035601/form4.xml","form_type":"4"}},{"id":1443103,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28803,"kind":"person","name":"Piccinini Laura","position":1,"cik":"0001875140","reported_name":"Piccinini Laura","relationship":{"officer":true,"officer_title":"SVP International"}}],"security":"Common Stock","published_at":"2024-08-03T01:55:48.000Z","date":"2024-07-17","kind":"exercise","planned":false,"acquired":true,"shares":4439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 4,439 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. (\"AngioDynamics\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 21, 2021."}],"balance_after":42491,"source":{"system":"sec-edgar","filing":"0001140361-24-035601","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875140/000114036124035601/form4.xml","form_type":"4"}},{"id":1442810,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2024-08-03T01:53:26.000Z","date":"2024-07-17","kind":"exercise","planned":false,"acquired":true,"shares":52378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 21, 2021, the reporting person received a target grant of 52,378 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2022, 2023 and 2024 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 56,279 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 21, 2021, the reporting person received a target grant of 52,378 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2022, 2023 and 2024 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 56,279 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 21, 2021, the reporting person received a target grant of 52,378 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2022, 2023 and 2024 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 56,279 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":52378},"source":{"system":"sec-edgar","filing":"0001140361-24-035600","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036124035600/form4.xml","form_type":"4"}}],"next_cursor":"2024-08-03T01:53:26.000000Z,1442810"}